Cooper Companies (NASDAQ:COO) Updates FY 2026 Earnings Guidance

Cooper Companies (NASDAQ:COO) updated its FY 2026 earnings guidance on Thursday. The company provided earnings per share guidance of 4.580-4.660 for the period, compared to the consensus earnings per share estimate of 4.620. The company issued revenue guidance of $4.3 billion-$4.3 billion, compared to the consensus revenue estimate of $4.3 billion.

Wall Street Analysts Forecast Growth

A number of equities research analysts have issued reports on the company. Mizuho set a $85.00 target price on Cooper Companies and gave the company an “outperform” rating in a research note on Thursday. The Goldman Sachs Group set a $61.00 price objective on shares of Cooper Companies in a research note on Wednesday, May 27th. Needham & Company LLC lifted their target price on Cooper Companies from $99.00 to $101.00 and gave the stock a “buy” rating in a report on Friday, March 6th. Piper Sandler set a $86.00 price target on Cooper Companies and gave the stock an “overweight” rating in a research note on Monday. Finally, Wells Fargo & Company reissued a “sell” rating on shares of Cooper Companies in a research note on Friday. One investment analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, six have given a Hold rating and two have given a Sell rating to the company. According to MarketBeat.com, Cooper Companies currently has an average rating of “Hold” and a consensus target price of $87.00.

Cooper Companies Stock Up 2.8%

Shares of Cooper Companies stock opened at $62.02 on Friday. The firm has a market cap of $12.10 billion, a price-to-earnings ratio of 30.70, a P/E/G ratio of 1.56 and a beta of 0.87. The company has a debt-to-equity ratio of 0.22, a current ratio of 1.34 and a quick ratio of 0.79. Cooper Companies has a 52-week low of $58.89 and a 52-week high of $89.83. The stock has a 50-day simple moving average of $65.17 and a 200-day simple moving average of $74.57.

Cooper Companies (NASDAQ:COO) last announced its quarterly earnings results on Thursday, June 4th. The medical device company reported $1.21 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.10 by $0.11. Cooper Companies had a return on equity of 10.34% and a net margin of 9.67%.The business had revenue of $1.08 billion during the quarter, compared to analyst estimates of $1.05 billion. During the same period in the previous year, the company earned $0.96 EPS. The firm’s revenue was up 7.9% on a year-over-year basis. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. On average, equities research analysts expect that Cooper Companies will post 4.62 earnings per share for the current fiscal year.

Key Stories Impacting Cooper Companies

Here are the key news stories impacting Cooper Companies this week:

• Positive Sentiment: Cooper Companies reported fiscal second-quarter EPS of $1.21, beating the $1.10 consensus, while revenue of $1.08 billion also topped estimates and rose 7.9% year over year. Cooper Companies earnings transcript
• Positive Sentiment: The company also reaffirmed growth momentum by posting improved profitability, with net margin of 9.67% and return on equity of 10.34%, which should support investor confidence. Cooper Companies press release
• Neutral Sentiment: Management guided fiscal 2026 EPS to $4.58-$4.66, which is close to the analyst view of $4.62 and suggests the outlook was acceptable, but not a major upside surprise. Cooper Companies stock page
• Neutral Sentiment: Several earnings-preview articles published ahead of the report likely added attention, but the main stock driver today appears to be the actual results and guidance. Yahoo Finance preview

Institutional Inflows and Outflows

Several institutional investors have recently added to or reduced their stakes in COO. Cresset Asset Management LLC increased its position in Cooper Companies by 7.5% in the third quarter. Cresset Asset Management LLC now owns 4,393 shares of the medical device company’s stock worth $301,000 after buying an additional 306 shares during the last quarter. Captrust Financial Advisors increased its position in Cooper Companies by 10.0% in the second quarter. Captrust Financial Advisors now owns 3,500 shares of the medical device company’s stock worth $249,000 after buying an additional 317 shares during the last quarter. Snowden Capital Advisors LLC increased its position in Cooper Companies by 10.0% in the second quarter. Snowden Capital Advisors LLC now owns 4,088 shares of the medical device company’s stock worth $291,000 after buying an additional 373 shares during the last quarter. Public Employees Retirement System of Ohio increased its position in Cooper Companies by 0.6% in the third quarter. Public Employees Retirement System of Ohio now owns 62,229 shares of the medical device company’s stock worth $4,266,000 after buying an additional 386 shares during the last quarter. Finally, Arkadios Wealth Advisors increased its position in Cooper Companies by 14.3% in the fourth quarter. Arkadios Wealth Advisors now owns 3,552 shares of the medical device company’s stock worth $291,000 after buying an additional 444 shares during the last quarter. 24.39% of the stock is owned by institutional investors.

Cooper Companies Company Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.